Management Profiles

Ernest M. Green,

President and C.E.O

Mr. Green joined BREONICS in 1997. From 1989 to 1997 he served as a Vice President and Director of Facilities and Regulatory Compliance for Alliance Pharmaceutical Corp. (ALLP) and from 1983 to 1989 was Vice President of Business Development and a Founder and Director of Otisville Biotech, Inc. (OBTI). At OBTI Mr. Green was instrumental in attaining a successful IPO for the company in 1984.

Lauren Brasile,

Founder, Executive Vice President and Chief Scientific Officer.

Ms. Brasile is the inventor of the patents that cover BREONICS' EMS and Immunosuppression technologies. She has over 20 years experience in transplantation immunology and organ preservation, she has published over 70 manuscripts in medical journals and 3 chapters in textbooks. She was the founder and President of VEC TEC Inc. where she directed the commercialization of a line of research products derived from her inventions that are now being marketed by that company. She served as Director of Research Laboratories for the Department of Surgery at Albany Medical Center and prior to that supervised the Transplant Research Labs at Ohio State University.

Frank J. Fitzpatrick

Vice President and C.F.O.

From 1989 to 1997 he served as Director of Financial Operations/Controller of Alliance Pharmaceutical Corp., Otisville, New York. Prior to Alliance Mr. Fitzpatrick served as Controller for Cubic Precision/Automatic Toll Systems, Teterboro, New Jersey a wholly-owned subsidiary of Cubic Corporation. Mr. Fitzpatrick began his career with Price Waterhouse in New York City in 1982. He is a graduate of Pace University, Pleasantville, New York and a Certified Public Accountant.

Bart M. Stubenitsky,

M.D., PhD., Vice President Medical Affairs

Dr. Stubenitsky joined BREONICS in 1998 as a Medical Consultant. He was a recipient of the Dutch Kidney Foundation Award in support of his research at the University of Maastricht in the Netherlands for his studies in Warm Organ Preservation.

Dr. Thomas Galouzis,

Director of Clinical Research.

Dr. Galouzis is a graduate of the University of Chicago School of Medicine with specialties in transplantation and general surgery. His work includes involvement with groundbreaking research that demonstrated the immunogenecity of the transplanted vasculature. Dr. Galouzis is also considered an expert in the field of laproscopic surgery and has been greatly involved in the development of new equipment and applications for the surgical technique.